International Journal of Medical and Pharmaceutical Research
2024, Volume-5, Issue-6 doi: 10.5281/zenodo.13373486
Original Research Article
Contraceptive Acceptance and Barriers Among Women of Reproductive Age in the vicinity of Urban Health and Training Centre, Indore (M.P.)-A Cross-Sectional Study in Central India
Published
Dec. 30, 2024
Abstract

Background: Despite national efforts to promote family planning, contraceptive nonacceptance remains high in India, particularly in urban slums. This study investigates the knowledge, attitudes, and practices influencing contraceptive use among married women of reproductive age in UHTC, Pardeshipura, Indore. Methods: A crosssectional study was conducted with 665 married women of reproductive age using a house-to-house survey. Simple random sampling was employed to select slum zones, and data were collected using a pre-designed and pre-tested proforma. Statistical analysis was conducted to identify associations between contraceptive use and demographic factors. Results:The contraceptive acceptance rate was 52.03%. Oral contraceptive pills were the most commonly used method (26.91%), followed by condoms (10.97%). Non-users (47.96%) cited barriers such as religious restrictions (15.49%), spousal disapproval (12.63%), and lack of knowledge (6.47%). Acceptance was significantly associated with literacy (p < 0.05), occupation (p < 0.001), and socioeconomic status (p < 0.05). Conclusion: Literacy status, socioeconomic-status and occupation were significantly associated with the use of contraceptives. Targeted educational initiatives and male involvement in family planning are needed to address cultural and informational barriers. Strengthening urban health systems is crucial for improving access to contraceptives.

Recommended Articles
Loading Image...
Volume-5, Issue-6
Citations
961 Views
351 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved